[gtranslate]
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
[gtranslate]
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NCTF 135 HA Program

Skin Revitalisation for Radiant, Hydrated Skin

NCTF 135 HA Program

Your skin knows how to renew itself. Sometimes it just needs the right ingredients — delivered to exactly the right place. Topical skincare can only reach so far. The real work of collagen, elastin, and hydration happens deeper — in the dermis, where fibroblasts live.

The NCTF 135 HA Program delivers 60 bioactive ingredients precisely to that level, creating the conditions for your skin to rebuild from within. Not a filler program. Not a surface treatment. Something more fundamental. Here’s everything you need to know to decide if it’s right for you.

What Is the NCTF 135 HA Program

What Is the NCTF 135 HA Program?

The NCTF 135 HA Program is a polyrevitalizing injectable solution containing 60 bioactive ingredients — including non-crosslinked hyaluronic acid, 24 amino acids, 12 vitamins, 6 minerals, 6 co-enzymes, 5 nucleosides, and glutathione — delivered through micro-injections directly into the dermis to stimulate fibroblast activity, boost collagen and elastin production, restore deep hydration, and improve overall skin quality. Developed by FILLMED Laboratories (France) with over 40 years of clinical use worldwide.

60 Ingredients — Each with a Purpose

What makes the NCTF 135 HA Program fundamentally different from simple hyaluronic acid skin booster programs is the complexity and intentionality of its formulation. Each ingredient group plays a specific role in fibroblast activation and collagen production:

(non-crosslinked, 5 mg/mL) — Hydrates and plumps the dermis by retaining up to 1,000 times its weight in water. Unlike crosslinked HA filler programs, this form integrates into the skin's existing matrix without adding volume.

— The building blocks of proteins, essential for collagen and elastin synthesis. Four are particularly critical: Glycine, Proline, Hydroxyproline, and Lysine — the key amino acids that form the triple-helix structure of collagen molecules. Without an adequate supply at the dermal level, fibroblasts cannot produce collagen efficiently — regardless of how strongly they're stimulated.² ³

— Including Retinol (Vitamin A) for regulation of cellular activity and protection of collagen from MMP degradation; Ascorbic Acid (Vitamin C) for collagen fibre conversion; and Tocopherol (Vitamin E) for anti-inflammatory and photoprotective effects.

— Precursors for DNA and RNA synthesis, regulating the genes responsible for collagen and elastin production.

— Including NAD, NADP, and CoA — metabolic cofactors that drive the enzymatic reactions necessary for cell metabolism. Without them, fibroblasts lack the energy for protein synthesis.

— Magnesium, Sodium, Potassium, Calcium, Chloride, and Phosphate, supporting biochemical reactions including collagen production.

— One of the body's most powerful antioxidants. Neutralises free radicals and reduces oxidative stress — a major driver of premature ageing and fibroblast dysfunction.

Put simply: rather than stimulating the skin with energy (as lasers and RF devices do) or filling it with structural gel (as filler programs do), the NCTF 135 HA Program nourishes the skin at the cellular level — giving fibroblasts every ingredient they need to resume producing collagen, elastin, and hyaluronic acid naturally. Think of it as restocking a factory with raw materials, energy, and instructions.

NCTF 135 HA Program vs Skin Booster Programs

The injectable skin booster market has grown significantly — with options ranging from simple hyaluronic acid hydrators to polynucleotide-based products. Here’s how the NCTF 135 HA Program is positioned differently.

Polyrevitalization vs. Simple Hydration

Most skin booster programs contain 1–3 active ingredients — typically hyaluronic acid, sometimes with added vitamins or amino acids. The NCTF 135 HA Program contains 60 active ingredients across 7 functional categories, each designed to support a different aspect of fibroblast metabolism and skin renewal. This polycomponent approach is based on the scientific principle that ageing fibroblasts need multiple substrates simultaneously — not just one stimulus — to restore their biosynthetic activity.¹

A published review in Clinical, Cosmetic and Investigational Dermatology (Prikhnenko, 2015) concluded that the NCTF 135 HA Program’s complex formulation creates a favourable microenvironment for optimal fibroblast function — addressing energy supply (co-enzymes), raw materials (amino acids), genetic regulation (nucleosides), oxidative protection (glutathione/vitamins), and hydration (HA) simultaneously.¹

Not a Filler Program — A Cellular Treatment

The NCTF 135 HA Program uses non-crosslinked hyaluronic acid, meaning it integrates into the skin’s existing moisture matrix rather than sitting as a discrete gel deposit. It doesn’t add volume, lift tissue, or change facial proportions. It improves the quality of the skin itself: hydration, density, firmness, radiance, texture, and fine lines.

This makes it ideal for patients who want their skin to look healthier and more luminous without any visible change in facial features — and for areas like the neck and décolletage where traditional filler programs are less appropriate.

40+ Years of Clinical Validation

The NCTF 135 HA Program has been used clinically since the 1980s, supported by multiple clinical trials (including the HEBE 2 and HEBE 3 studies), in vitro and ex vivo laboratory research, and a published 10-year comprehensive review covering cellular, histological, and clinical evidence.⁴ ⁵ ⁶

Key Benefits — What the Research Shows

+ 0 %
GLOW ENHANCEMENT
+ 0 %
OF SKIN ELASTICITY
0 %
HYDRATION
Ref. Laboratoires FILLMED. NCTF® 135 HA HCP brochure. Paris: Laboratoires FILLMED; 2025.

At BSL Clinic, we believe you deserve to know exactly what a treatment can — and cannot — do before you commit. Here’s what the research shows, presented without exaggeration.

1. Fibroblast Activation — The Cellular Engine of Skin Renewal

In vitro studies demonstrate that the NCTF 135 HA Program produces statistically significant increases in fibroblast activity:

  • Cell multiplication: 147% increase for normal fibroblasts and 148% for aged fibroblasts vs untreated controls (P<0.01)
  • Intracellular collagen synthesis: 165% increase for normal fibroblasts, 166% for aged fibroblasts (P<0.01)
  • Extracellular collagen synthesis: 200% increase for normal fibroblasts, 256% for aged fibroblasts (P<0.01)
  • Oxidative stress protection: 72% reduction in intracellular hydrogen peroxide and 90% reduction in lipid peroxides after UV exposure (P<0.01)

The fact that aged fibroblasts showed equal or greater response than normal fibroblasts matters: it confirms that ageing fibroblasts aren’t dead — they’re dormant, and they can be reactivated when given the right nutritional environment.¹

2. Wrinkle Reduction — Clinically Measured

The HEBE 2 study (2019, randomised controlled, 10 centres, n=147) demonstrated that three sessions of the NCTF 135 HA Program significantly reduced superficial wrinkles on the face, neck, and décolletage versus anti-ageing cream alone — with statistically significant results at Day 75, maintained through Day 120.⁵

A separate 10-year review reported a 50% decrease in mean wrinkle score (P<0.0001), with significant improvements in skin tonicity, hydration, and radiance across five treatment sessions.⁴

3. Skin Hydration — Measurable and Rapid

Skin hydration increased significantly within 7 days of the final NCTF 135 HA Program injection in the HEBE 2 trial. Over 83% of patients reported enhanced skin hydration following treatment.⁵

4. Radiance, Density, and Texture — Comprehensive Quality Improvement

The Grand-Vincent et al. clinical assessment (2017, n=40) measured outcomes after 5 sessions:

  • Skin radiance: 52% improvement in 88% of participants
  • Wrinkle volume: 33% reduction, with 67% showing visible improvement
  • Pore size: 59% of participants experienced measurable reduction
  • Dermis density and thickness: Measurably increased, reflecting genuine structural improvement⁶

5. Periocular Rejuvenation — Eye Area Results

A 2024 prospective study (Nava-Castañeda et al., n=32) evaluated the NCTF 135 HA Program specifically for periocular skin quality. After three sessions, Face-Q satisfaction improved from 44.22 to 63.16 (P=0.0001), eye appearance from 41.22 to 57.00 (P=0.0001), and skin quality score from 11.52 to 5.31 (P=0.0001).⁷

A note from BSL Clinic: The NCTF 135 HA Program works progressively and cumulatively. The first session delivers an immediate glow and hydration boost — but the deeper, structural improvements in collagen density, firmness, and wrinkle reduction build over the full protocol of 3 sessions. This is a treatment that rewards patience and consistency.

What Is the NCTF 135 HA Program
What Is the NCTF 135 HA Program
What Is the NCTF 135 HA Program

How the NCTF Treatment Program Works

The Delivery: Micro-Injections into the Dermis

The NCTF 135 HA Program is delivered through multiple micro-injections directly into the papillary dermis — the layer where fibroblasts reside. Using a fine needle (30G or 32G), your doctor places small deposits of solution approximately 1–1.5 cm apart, creating micro-papules that gradually diffuse into surrounding tissue.

Each injection point delivers approximately 0.05 mL of the solution, creating a localised zone of bioactive nutrients that fibroblasts can access directly. The non-crosslinked hyaluronic acid provides immediate hydration while the amino acids, vitamins, co-enzymes, nucleosides, and minerals create the metabolic environment for sustained collagen and elastin production.

The Biological Response: What Happens After Injection

  • Hours 1–24

    The non-crosslinked HA begins hydrating the dermis immediately. Micro-papules are visible but flatten within 24 hours as the solution diffuses. Most patients notice an immediate "glow" effect.

  • Days 1–7

    Fibroblasts begin responding to the amino acid, vitamin, and co-enzyme supply. GAGs (glycosaminoglycans) content in the deep dermis increases significantly — confirmed by immunostaining in ex vivo studies within 7 days of injection.⁴

  • Days 7–21

    Fibroblast proliferation and collagen synthesis accelerate — aligning with the 21-day cell cycle, which is why sessions are spaced 3 weeks apart.

  • Weeks 3–12

    Progressive collagen and elastin accumulation. Skin density, firmness, and texture continue to improve with each session.

  • Months 3–6+

    With a completed protocol, the cumulative effect of multiple sessions produces sustained improvement in skin quality, hydration, radiance, and fine lines.

Why 3 Sessions, 3 Weeks Apart

The standard NCTF 135 HA Program consists of 3 sessions spaced 21 days apart — aligned with the skin’s natural cell renewal cycle. Each session reinforces and amplifies the previous one:

  • Session 1: Initial fibroblast activation and hydration
  • Session 2: Amplification of collagen and elastin production
  • Session 3: Consolidation and stabilisation of results

Maintenance treatments every 3–6 months sustain the effects long-term.

Line Around The Eyes

- 0 %
Advertising Image

Cheek-Lines

- 0 %
Advertising Image

Smile Lines

- 0 %
Advertising Image

Neck-Lines

- 0 %

Advertising Image

Advertising Image

Target Areas: Face, Eyes, Neck & More

Full Face

The most popular treatment area. The NCTF 135 HA Program improves hydration, radiance, firmness, pore size, and fine lines across all facial zones — forehead, cheeks, perioral area, jawline, and chin. One vial is distributed evenly between both sides of the face per session.

Periorbital Area (Around the Eyes)

The delicate skin around the eyes is among the first to show ageing and among the most difficult to treat safely with energy devices. The NCTF 135 HA Program has been specifically studied for periocular rejuvenation, showing statistically significant improvement in eye appearance satisfaction and skin quality.⁷ At BSL Clinic, we find that the eye area responds particularly well — delivering noticeable improvement in fine lines, dark circles, and crepey texture without the risks associated with ablative treatments in this sensitive zone.

Neck and Décolletage

These areas age visibly but are difficult to treat aggressively due to thinner skin and higher complication risk. The HEBE 2 study specifically included the neck and décolletage, confirming statistically significant wrinkle reduction in both areas.⁵

Hands

The dorsal hands lose volume and skin quality with age. The NCTF 135 HA Program improves skin hydration, thickness, and texture in the hands — complementing filler program–based volume restoration.

Scalp (Hair Restoration Support)

The NCTF 135 HA Program is also used for scalp mesotherapy to support hair follicle health and reduce hair thinning — though this is outside the scope of this skin-focused article.

Results: What Changes After Each Session

Clinical Evidence: What the Research Shows

The most robust clinical evidence for the NCTF 135 HA Program. Patients were assigned 3:1 to receive three NCTF 135 HA Program sessions (plus anti-ageing cream) or cream alone.

Results at Day 75 and Day 120:

  • Wrinkle reduction: Statistically significant in face, neck, and décolletage versus control
  • Facial radiance: Significantly improved versus control
  • Skin hydration: Significantly increased 7 days after last injection
  • Self-esteem: Statistically significant improvement at D75 and D120
  • Tolerability: Well-tolerated with no serious adverse events⁵

Robin et al. compiled a decade of laboratory and clinical evidence:

  • In vitro: The NCTF 135 HA Program increased collagen synthesis by 165–256%, cell multiplication by 147–148%, UV protection by 72–90% (all P<0.01)
  • Ex vivo: Increased cell proliferation, elastin production, collagen production, and GAGs content
  • Clinical Trial 1: Wrinkle score decreased by 50% (P<0.0001), with significant improvement in tonicity, hydration, and radiance
  • Clinical Trial 2: Significantly increased dermis density and thickness, skin homogeneity and radiance, decreased pore size and wrinkle depth⁴

Three sessions of the NCTF 135 HA Program produced significant improvement in periocular skin quality — Face-Q scores improving from 44 to 63 for facial appearance and 41 to 57 for eye appearance (both P=0.0001).⁷

Five sessions produced: 52% improvement in skin radiance (88% of participants), 33% wrinkle volume reduction (67%), 59% pore size reduction, and measurable increases in dermis density and thickness.⁶

Treatment outcomes from published peer-reviewed studies. Individual results may vary.

Is This Program Right for You?

You may be a good candidate if you:

The NCTF 135 HA Program is not recommended if you:

A note from BSL Clinic: The NCTF 135 HA Program is one of the most versatile treatments we offer — because it works with almost everything else. Whether you’re preparing for a laser resurfacing session, recovering from an energy-based treatment, or simply want your skin to look healthier and more radiant, this program can be tailored to fit your needs. A consultation will help us determine the best approach for your skin.

Safety & Side Effects

Minimal Downtime — Designed for Active Lifestyles

Safety & Side Effects

Immediately after treatment:

Mild redness, small papules, and slight swelling may appear. These are normal and typically resolve within a few hours to 24–48 hours.

First 24 hours:

Avoid touching the treated area, intense exercise, direct sun exposure, and makeup.

Days 2–3:

Most patients return to completely normal activities with no visible signs of treatment.

Safety Profile

The NCTF 135 HA Program has been used clinically for over 40 years with a well-established safety record. The HEBE 2 study (n=147) reported no serious adverse events. Side effects are limited to the injection procedure itself — temporary redness, mild swelling, and small papules that resolve spontaneously.⁵

Allergic reactions are very rare but possible. Your doctor will review your medical history and any known sensitivities before treatment.

Your Treatment Journey at BSL Clinic
Your Treatment Journey at BSL Clinic

Your Treatment Journey at BSL Clinic

Consultation

Before Treatment

During Treatment

After Treatment

The Recommended Protocol

NCTF Program Combined with Other Treatments

One of the NCTF 135 HA Program’s greatest strengths is its role as a facilitator of other aesthetic treatments. Published research supports its use in combination with both anti-wrinkle injections and calcium hydroxylapatite — with results that exceed what either treatment achieves alone.

NCTF 135 HA program with anti-wrinkle injections at BSL Clinic for wrinkle reduction and improved skin quality

1. NCTF 135 HA Program + Anti-Wrinkle Injections — Wrinkles and Skin Quality Together

Anti-wrinkle injections relax the muscles that create dynamic wrinkles — but they don’t improve the quality of the skin itself. The NCTF 135 HA Program addresses the other half of the equation: hydration, firmness, radiance, and structural integrity.

A published clinical study on forehead rejuvenation compared anti-wrinkle injections alone (one side) versus the NCTF 135 HA Program + anti-wrinkle injections (other side) in a split-face design. Results at Day 60:

Wrinkle improvement (Bazin forehead scale):
Skin quality scoring (all P<0.001):
Global Aesthetic Improvement (GAIS) at D60:

The combination significantly improves skin quality and decreases wrinkles to a degree that is substantially superior to anti-wrinkle injections without the biorevitalization component.

At BSL Clinic, we commonly offer this combination — beginning with the NCTF 135 HA Program to optimize skin quality, followed by anti-wrinkle injections for dynamic wrinkle relaxation. This “inside-out” approach addresses both the skin and the muscle — for results that look natural and comprehensive.

2. NCTF 135 HA Program + CaHA Program — The "Skin Priming" Concept

This is one of the most innovative combination strategies in regenerative aesthetics — and it addresses a clinical observation that BSL Clinic finds particularly relevant: some patients respond less favourably to biostimulator treatments than others, and the reason may be a micronutrient deficit at the dermal level.

The concept of “skin priming” was introduced by Theodorakopoulou et al. (2023, Journal of Drugs in Dermatology), who hypothesised that delivering amino acids and co-enzymes via the NCTF 135 HA Program could create a nutritional reservoir that optimises the skin’s regenerative response to the CaHA Program. In other words: the CaHA Program tells fibroblasts to produce collagen, but the NCTF 135 HA Program gives them the raw materials and energy to actually do it.⁹

The clinical evidence:

In a published case series, patients received a 1:1 mixture of CaHA (Radiesse Program) and NCTF 135 HA Program as a single treatment. Results after one session:

The ex vivo evidence:

Mixing the NCTF 135 HA Program solution with CaHA at a 2:1 ratio increased pro-collagen Type I production by +49% compared to saline+CaHA (285.7 vs. 191.5 pg/mL) — confirming a synergistic effect at the molecular level.¹⁰

The mechanism:

The CaHA Program works through mechanical stimulation — its microspheres activate fibroblasts via mechano-receptors. The NCTF 135 HA Program works through physiological stimulation — providing the 24 amino acids, 6 co-enzymes, and 12 vitamins that fibroblasts need for optimal protein synthesis. Combined, the mechanical signal and the nutritional support produce a “1+1=3” effect — greater collagen production than either treatment delivers alone.

Why BSL Clinic uses this approach: The skin priming concept is especially valuable for patients over 45, or those with chronologically mature skin where baseline fibroblast activity is significantly reduced. By priming the skin with the NCTF 135 HA Program — either mixed directly with the CaHA Program or delivered in a preceding session — we can enhance the collagen-building response and produce more consistent, visible results across a wider range of patients.

FAQs NCTF 135 HA Program

FAQs

NCTF 135 HA Program

1. What is the NCTF 135 HA Program?

The NCTF 135 HA Program (New Cellular Treatment Factor) is a CE-certified polyrevitalizing injectable solution containing 60 bioactive ingredients — including non-crosslinked hyaluronic acid, 24 amino acids, 12 vitamins, 6 minerals, 6 co-enzymes, 5 nucleosides, and glutathione. It is injected into the dermis to stimulate fibroblast activity, boost collagen and elastin production, and restore deep skin hydration. Developed by FILLMED Laboratories (France) with over 40 years of clinical use.

2. How is the NCTF 135 HA Program different from dermal filler programs or skin booster programs?

Unlike filler programs, the NCTF 135 HA Program does not add volume or change facial proportions. Unlike simple skin booster programs that contain only HA, it delivers 60 active ingredients targeting every aspect of fibroblast metabolism — raw materials (amino acids), energy (co-enzymes), genetic regulation (nucleosides), antioxidant protection (glutathione/vitamins), and hydration (HA). It improves skin quality from within rather than adding external volume.

3. How many sessions do I need?

The standard protocol is 3 sessions spaced 21 days apart. Results are cumulative — each session builds on the previous one. Maintenance sessions every 3–6 months sustain improvement. For more mature skin, an initial intensive course of 4–6 sessions may be recommended.

4. When will I see results?

Most patients notice an immediate glow and hydration boost after the first session. Progressive improvements in firmness, texture, radiance, and fine lines develop over the full 3-session protocol. Clinical studies show significant measurable improvement at Day 75 maintained through Day 120.⁵

5. Does the treatment hurt?

The NCTF 135 HA Program is delivered through fine 30G or 32G needles. Most patients describe mild prickling — well-tolerated, especially with topical numbing cream. The procedure takes 15–45 minutes.

6. Is there any downtime?

Minimal. Mild redness and small papules may be visible for a few hours to 24 hours. Most patients resume normal activities immediately.

7. Can the NCTF 135 HA Program be combined with other treatments?

Yes — and this is one of its greatest strengths. Published research supports combining the NCTF 135 HA Program with anti-wrinkle injections (significantly better wrinkle and skin quality outcomes) and with the CaHA Program (skin priming increases collagen production by 49%). It can also complement laser treatments, PRP, and other energy-based devices.

8. What areas can be treated?

Face (full face including periorbital area), neck, décolletage, and hands. The HEBE 2 study validated efficacy on face, neck, and décolletage.⁵ A dedicated study confirmed periocular skin quality improvement.⁷

9. What makes BSL Clinic's approach to NCTF different?

We use the NCTF 135 HA Program as part of a comprehensive skin strategy — not as an isolated treatment. Whether it’s priming your skin before a biostimulator, supporting recovery after laser resurfacing, or enhancing the results of anti-wrinkle injections, we integrate it into a personalized plan based on your specific skin needs.

10. Who should NOT have the NCTF 135 HA Program?

Patients who are pregnant or breastfeeding, have active skin infections, known allergy to any component (particularly HA), or autoimmune skin conditions. A consultation determines suitability.

Summary: The Evidence at a Glance

If you’ve read this far and want the short version — here it is.

The NCTF 135 HA Program has been studied for over 40 years, across lab settings, randomised controlled trials, and real patient assessments. The picture that emerges is consistent:

It activates dormant fibroblasts. Aged fibroblasts showed up to 148% more cell multiplication and 256% more collagen output in lab studies — not because they were failing, but because they were missing the right building blocks.¹

It reduces wrinkles — measurably. A 10-year clinical review found wrinkle scores dropped by 50% across five sessions. The landmark HEBE 2 trial confirmed significant improvement at Day 75, sustained through Day 120.⁴ ⁵

It works on the eye area. A dedicated periocular study showed Face-Q satisfaction scores jumped from 44 to 63 — a meaningful shift in how patients felt about how they looked.⁷

It makes other treatments work better. Combined with anti-wrinkle injections, wrinkle scores improved more than 4× versus anti-wrinkle injections alone. Combined with the CaHA Program, collagen production increased by 49% — confirmed in the lab.⁸ ⁹ ¹⁰

It works for most skin types, with minimal downtime. No serious adverse events in the HEBE 2 study (n=147). Most patients return to normal life the same day.⁵

This is not a treatment that works through one mechanism and hopes for the best. It works because it gives the skin everything it needs — simultaneously — to do what it was always designed to do.

Take the First Step Toward Skin That Glows from Within

The NCTF 135 HA Program isn’t about covering up what’s changed — it’s about giving your skin the biological tools it needs to function at its best again. Hydration, firmness, radiance, texture — these aren’t cosmetic additions. They’re signs of healthy, well-nourished skin that is actively producing the collagen, elastin, and hyaluronic acid it needs to look and feel vibrant.

If your skin has been telling you that something is missing — and topical products alone aren’t enough — the NCTF 135 HA Program may be the answer.

At BSL Clinic, the right treatment always starts with the right conversation.

Book a consultation. Let us assess your skin, explain what’s realistic, and design a plan that works for you.

Certificate Fillmed

Medically Reviewed by :

Wipanee Akarapusit, MD Medical License No. 39678

Wipanee Akarapusit, MD

Medical License No. 39678 — The Medical Council of Thailand

BSL Clinic, Bangkok

  1. Prikhnenko S. Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality. Clin Cosmet Investig Dermatol. 2015;8:151–157. DOI: 10.2147/CCID.S76721.
  2. FILLMED Laboratories. NCTF 135 HA Product Information. Available from: https://fillmed.com/revitalize-nctf/
  3. FILLMED Laboratories. 60 Essential Actives Ingredients — Product Technical Data Sheet.
  4. Robin S, Fanian F, Courderot-Masuyer C, et al. Efficacy of a Biorevitalizing-Filler Solution on All Skin Aspects: 10 Years Approach Through in Vitro Studies and Clinical Trials. J Cosmet Dermatol Sci Appl. 2017;7(4):291–305. Available from: https://www.scirp.org/journal/paperinformation?paperid=107606 
  5. Fanian F, Deutsch JJ, Bousquet MT, Boisnic S, Andre P, Catoni I, Beilin G, Lemmel C, Taieb M, Gomel-Toledano M, Issa H, Garcia P. A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study. J Cosmet Dermatol. 2023;22(10):2747–2756. Available from: https://www.researchgate.net/publication/373130595_A_hyaluronic_acid-based_micro-filler_improves_superficial_wrinkles_and_skin_quality_a_randomized_prospective_controlled_multicenter_study 
  6. Grand-Vincent A, Boisnic S, Salomon C, Prinderre P, Piccerelle P. Clinical assessment of a mesotherapy formulation for skin rejuvenation in healthy volunteers. J Cosmet Dermatol Sci Appl. 2017;7(4):291–305.
  7. Nava-Castañeda A, et al. Treatment of Periocular Skin Aging and Improvement of Skin Quality with NCTF 135 HA Polyrevitalization Injections. Athenaeum Scientific Publishers. 2024.
  8. Picard P. The Combined Effect of Anti-Wrinkle Injections with a Biorevitalizing Treatment on Forehead Rejuvenation: A Case Series. J Cosmetic Sci Appl. (FILLMED clinical data).
  9. Theodorakopoulou E, McCarthy A, Perico V, et al. Optimizing Skin Regenerative Response to Calcium Hydroxylapatite Microspheres Via Poly-Micronutrient Priming. J Drugs Dermatol. 2023;22(9):925–934. DOI: 10.36849/JDD.7405.
  10. FILLMED Laboratories. NCTF + CaHA Ex Vivo Study: Stimulation of Pro-Collagen Type I — Evaluation on Explant 3 Weeks After Treatment. Internal research data, 2024.